Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Papillon Capital is a venture capital firm founded in 2012 and headquartered in Bengaluru, India. The firm specializes in early-stage investments, particularly in companies that focus on sustainable infrastructure across various sectors. Papillon Capital is dedicated to supporting businesses that are not only commercially viable but also contribute positively to society and the environment. The firm operates with a clear mission to finance solutions that address pressing societal needs while ensuring financial returns.
As of now, specific details regarding the team size, assets under management (AUM), or the total number of funds are not publicly disclosed. However, the firm has established itself as a player in the impact investing space, particularly in India and other emerging markets. Papillon Capital's notable portfolio company is MedGenome Inc., a genomics company co-invested with Emerge Ventures. The firm has a history of focusing on sectors that align with its mission of sustainable development.
Papillon Capital primarily invests in early-stage companies, specifically targeting pre-Series A and B stages. The firm emphasizes capital-efficient and tech-enabled business models that can thrive in emerging economies. Key sectors of interest include energy, healthcare, climate, housing, education, financial inclusion, urban infrastructure, and transport. This broad focus allows Papillon Capital to address various societal challenges while seeking commercially attractive opportunities.
The firm’s investment thesis centers around impact-oriented ventures that contribute to sustainable infrastructure. Papillon Capital looks for companies that demonstrate strong management teams, innovative solutions, and the potential for significant social and environmental impact. The firm’s geographic focus is primarily on India, but it also considers opportunities in other emerging markets where sustainable infrastructure is critical.
Papillon Capital's portfolio includes a notable investment in MedGenome Inc., a genomics company that focuses on providing genetic testing and research services. This investment was made in collaboration with Emerge Ventures, highlighting Papillon Capital's strategy of co-investing to leverage additional expertise and resources. MedGenome is recognized for its contributions to the field of genomics, particularly in the Indian market.
Currently, no additional portfolio companies have been publicly disclosed, indicating a selective investment approach. The firm’s focus on sustainable infrastructure suggests that future investments may align with sectors that address critical societal needs, particularly in energy, healthcare, and climate.
What are Papillon Capital's investment criteria?
Papillon Capital focuses on early-stage companies that are capital-efficient and tech-enabled. The firm seeks businesses that can thrive in emerging markets and contribute positively to society and the environment. Key sectors include energy, healthcare, climate, housing, education, financial inclusion, urban infrastructure, and transport.
How can startups apply or pitch to Papillon Capital?
While specific application procedures are not publicly available, startups interested in pitching to Papillon Capital should prepare a comprehensive business plan that outlines their value proposition, market potential, and alignment with the firm’s focus on sustainable infrastructure. A warm introduction may enhance the chances of consideration.
What makes Papillon Capital different from other venture capital firms?
Papillon Capital distinguishes itself through its commitment to impact investing in sustainable infrastructure. The firm prioritizes investments that are not only financially viable but also contribute to broader societal goals, making it an attractive partner for startups with a social mission.
What is the typical check size for investments?
Papillon Capital typically invests between $1 million and $5 million per deal, focusing on early-stage companies that meet their investment criteria.
What is the geographic scope of Papillon Capital's investments?
The firm primarily targets investments in India and other emerging markets, where the need for sustainable infrastructure solutions is critical. This geographic focus allows Papillon Capital to address pressing societal challenges effectively.
What kind of post-investment involvement can portfolio companies expect?
While specific details about post-investment involvement are not disclosed, Papillon Capital emphasizes sustainable and socially responsible business practices, suggesting that they may provide guidance and support to portfolio companies in aligning their operations with these principles.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.